Vasculitis News and Research

Latest Vasculitis News and Research

Radiation-induced vascular damage could be treated with IL-1 inhibitors

Radiation-induced vascular damage could be treated with IL-1 inhibitors

Association found between gene variant and lung disease in the form of systemic vasculitis

Association found between gene variant and lung disease in the form of systemic vasculitis

Researchers reveal promising biomarker for vascular disease relapse

Researchers reveal promising biomarker for vascular disease relapse

Immune checkpoint inhibitors induce rheumatic and musculoskeletal diseases

Immune checkpoint inhibitors induce rheumatic and musculoskeletal diseases

Meta-analysis reveals effective treatment options for urticarial vasculitis

Meta-analysis reveals effective treatment options for urticarial vasculitis

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

FDA approves update to Rituxan label to include information on treatment of rare forms of vasculitis

FDA approves update to Rituxan label to include information on treatment of rare forms of vasculitis

Health Care Apps and the Empowered Patient

Health Care Apps and the Empowered Patient

CNDA approves KEYTRUDA for treatment of advanced melanoma

CNDA approves KEYTRUDA for treatment of advanced melanoma

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Pfizer announces FDA approval of biosimilar to Neupogen

Pfizer announces FDA approval of biosimilar to Neupogen

A systematic approach towards diagnosis and treatment of rheumatoid arthritis

A systematic approach towards diagnosis and treatment of rheumatoid arthritis

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Study: Lenabasum has acceptable safety and tolerability in diffuse cutaneous systemic sclerosis

Study: Lenabasum has acceptable safety and tolerability in diffuse cutaneous systemic sclerosis

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Report highlights needs, experiences of people with rare autoimmune rheumatic diseases

Report highlights needs, experiences of people with rare autoimmune rheumatic diseases

Texas Biomed and The Children’s Hospital of San Antonio join forces to cure mysterious condition

Texas Biomed and The Children’s Hospital of San Antonio join forces to cure mysterious condition

Studies find alarming shortage of rheumatology workforce in future

Studies find alarming shortage of rheumatology workforce in future